Publications

5808 Results

A phase III randomized trial of anastrozole and fulvestrant versus anastrozole or sequential anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: Final survival outcomes of SWOG S0226

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;D Lew;D Hayes;J Gralow;H Linden;R Livingston;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster discussion
Year
2017
Research Committee(s)
Breast
Study Number(s)
S0226

Final analysis of SWOG S0230/Prevention of Early Menopause Study (POEMS)

Authors
HCF Moore;JM Under;KA Phillips;F Boyle;E Hitre;A Moseley;D Porter;PA Francis;LJ Goldstein;HL Gomez;C Vallejos;AH Partridge;S Dakhil;A Garcia;J Gralow;JM Lombard;JF Forbes;S Martino;W Barlow;C Fabian;L Minasian;F Meyskens;RD Gelber;G Hortobagyi;K Albain
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Breast
Study Number(s)
S0230

Randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in women with early stage breast cancer (S1200)

Authors
D Hershman;JM Unger;H Greenlee;J Capodice;D Lew;A Kengla;M Melnik;C Jorgensen;W Kreisle;L Minasian;M Fisch;NL Henry;K Crew
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), oral
Year
2017
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S1200

Association Between Cardiovascular Risk Factors and Cardiac Events Among Breast Cancer Patients Enrolled in SWOG Clinical Trials

Authors
D Hershman;C Till;J Wright;S Ramsey;W Barlow;JM Unger
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Breast
Study Number(s)
S0012, S0221, S0226, S0307, S0500

Long-term follow-up (FU) of (Alliance) CALGB 40502/NCCTG N063H: A randomized Phase III Trial of Weekly Paclitaxel (P) compared to Weekly Nanoparticle Albumin Bound Nab-Paclitaxel (NP) or Ixabepilone (Ix) +/- Bevacizumab (B) as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer (MBC)

Authors
H Rugo;W Barry;A Moreno-Aspitia;A Lyss;L Huebner;EL Mayer;M Naughton;R Layman;LA Carey;RA Somer;D Toppmeyer;M Velasco;E Perez;CA Hudis;E Winer
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster discussion
Year
2017
Research Committee(s)
Breast

Independent validation of EarlyR gene signature in E2197: a randomized clinical trial comparing doxorubicin plus docetaxel to doxorubicin plus cyclophosphamide as adjuvant chemotherapy in breast cancer

Authors
S Badve;V Wang;S Willis;B Leyland-Jones;Y Gokmen-Polar;LN Shulman;S Martino;J Sparano;E Perez;N Davidson;L Goldstein;S Buechler
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Breast
Study Number(s)
E2197

Mutations in Acute Promyelocytic Leukemia are Similar at Diagnosis and Relapse and ETV6 may be a Molecular Biomarker of Decreased Disease Free Survival and High Risk Disease Independent of White Blood Count

Authors
E Stein;A Viny;S Devlin;E Paietta;F Appelbaum;J Lancet;R Larson;B Powell;P Wiernik;R Levine;M Tallman
Journal / Conference
International Symposium on Acute Promyelocytic Leukemia (September 24-27, 2017, Rome, Italy), oral presentation
Year
2017
Research Committee(s)
Leukemia
Study Number(s)
C9710, S0535

Practice makes perfect- The rest of the story in testicular cancer as a model curable neoplasm

Authors
T Tandstad;C Kollmannsberger;B Roth;C Jeldres;S Gillessen;K Fizazi;S Daneshmand;W Lowrance;N Hanna;C Albany;R Foster;G Cohn-Cedermark;D Feldman;T Powles;M Lewis;P Grimison;D Bank;CR Porter;P Albers;M De Santis;S Srinvas;G Bosl;CR Nichols
Journal / Conference
Journal of Clinical Oncology Nov 1;35(31):3525-3528; Aug 30 [Epub ahead of print]
Year
2017
Research Committee(s)
Genitourinary
PMID
PMID28854068
PMC
PMC5791831

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

Authors
K Crew;G Anderson;D Hershman;M Terry;D Lew;M Yee;EA Brown;S Kairouz;L Minasian;L Ford;B Arun;M Neuhouser;P Brown
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0812

SWOG S1418/NRG -BR006: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (>pN1mic) After Neoadjuvant Chemotherapy

Authors
L Pusztai;W Barlow;P Ganz;NL Henry;J White;R Jagsi;J Mammen;D Lew;J Mejia;V Karantza;G Aktan;G Hortobagyi;E Mamounas
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Breast